CPT code 21013 is for the surgical removal of a deep tumor from the face that is less than 2 cm in size.
CPT code 21013 is used for the surgical procedure involving the excision of a deep tumor from the face that is less than 2 centimeters in size.
When billing for CPT code 21013 (Excision of tumor, soft tissue of face and/or scalp, subcutaneous; less than 2 cm), the following modifiers may be applicable:
1. Modifier 22 (Increased Procedural Services): Use this modifier if the procedure required significantly more work than typically required. This could be due to factors such as increased intensity, time, technical difficulty, severity of the patient's condition, or physical and mental effort required.
2. Modifier 50 (Bilateral Procedure): If the procedure was performed on both sides of the face, this modifier should be appended to indicate a bilateral procedure.
3. Modifier 51 (Multiple Procedures): Apply this modifier if multiple procedures were performed during the same surgical session. This helps to indicate that more than one procedure was carried out.
4. Modifier 59 (Distinct Procedural Service): Use this modifier to indicate that the procedure was distinct or independent from other services performed on the same day. This is particularly important if the procedures are not typically reported together but are appropriate under the circumstances.
5. Modifier 76 (Repeat Procedure by Same Physician): If the same procedure was repeated by the same physician, this modifier should be used to indicate the repeat service.
6. Modifier 77 (Repeat Procedure by Another Physician): If the procedure was repeated by a different physician, this modifier should be used to indicate the repeat service by another provider.
7. Modifier 78 (Unplanned Return to the Operating/Procedure Room): Use this modifier if the patient had to return to the operating room for a related procedure during the postoperative period.
8. Modifier 79 (Unrelated Procedure or Service by the Same Physician During the Postoperative Period): Apply this modifier if an unrelated procedure was performed by the same physician during the postoperative period of the initial procedure.
9. Modifier LT (Left Side): If the procedure was performed on the left side of the face, this modifier should be used to specify the location.
10. Modifier RT (Right Side): If the procedure was performed on the right side of the face, this modifier should be used to specify the location.
These modifiers help provide additional information about the circumstances under which the procedure was performed, ensuring accurate billing and reimbursement.
Medicare reimbursement for CPT code 21013, which pertains to the excision of a deep tumor in the face measuring less than 2 cm, depends on several factors including the specific Medicare Administrative Contractor (MAC) jurisdiction, the setting in which the procedure is performed, and the patient's individual Medicare plan.
As of the latest available data, Medicare does reimburse for CPT code 21013, but the reimbursement amount can vary. On average, the national Medicare reimbursement rate for this procedure is approximately $500 to $700. However, it is essential to verify the exact reimbursement rate with the local MAC, as rates can differ based on geographic location and other variables.
Healthcare providers should also ensure that the procedure is medically necessary and properly documented to meet Medicare's coverage criteria. For the most accurate and up-to-date information, consulting the Medicare Physician Fee Schedule (MPFS) or contacting the local MAC is recommended.
Discover how MD Clarity's RevFind software can meticulously read your contracts and detect underpayments down to the CPT code level, including specific codes like 21013 for excision of a facial tumor less than 2 cm deep. Ensure you're receiving accurate reimbursements from every payer. Schedule a demo today to see RevFind in action and safeguard your revenue.
Get paid in full by bringing clarity to your revenue cycle
Subscribe to the
Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
